Jubilant Life Sciences’ US-based arm Jubilant Discovery Services has entered into an agreement with Janssen Pharmaceutica NV to deliver pre-clinical candidates in the area of neuroscience to the Belgium-based firm. The agreement will cover an initial period of three years and will focus on multiple targets in the area of neuroscience.
According to the agreement, Janssen will transfer ongoing efforts on selected drug discovery targets to Jubilant and Jubilant will then carry out the research services and deliver pre-clinical candidates to Janssen for possible further development and commercialization. As per the deal in addition to research funding, Jubilant may also be eligible to receive payments at different intervals and royalties should Janssen successfully develop and commercialize the candidates.
The association will utilize Jubilant's global research network to include its new research facility in the US focused in the area of neuroscience, in addition to its India-based research centres.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1872.00 |
| Dr. Reddys Lab | 1289.80 |
| Cipla | 1310.05 |
| Zydus Lifesciences | 954.55 |
| Lupin | 2276.65 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: